Department of Urology, Apollo Main Hospitals, Chennai, India.
Department of Urology, Amrita Institute of Medical Science, Kochi, India.
Urologia. 2022 Aug;89(3):430-436. doi: 10.1177/03915603221097166. Epub 2022 May 28.
Minimal invasive surgeries (MIS) for large size adrenal tumors are still debatable. The objective is to evaluate the contemporary peri- and post-operative outcomes of patients undergoing (open = OA, laparoscopic = LA, and robotic = RA) adrenalectomies in three institutions.
Retrospectively gathered peri- and post-operative data of 235 patients, underwent adrenalectomy at three Institutions over a 7-year period (2013-2020) were analyzed. All patients underwent thorough radiological and endocrine workup.
Two hundred and thirty five patients who underwent adrenalectomy (OA ( = 29), LA ( = 146), and RA ( = 60)) were assessed. OA ( = 29) versus Minimally invasive surgery ( = 206) showed significant differences (median, value) in larger tumour size, cm (9.4 vs 5, ( = 0.0001)), longer operative time, mins (240 vs 100, ( = 0.0001)), longer hospital stay, days (8 vs 3,( = .0001)), Higher readmission rates (14% vs 1.9%), higher blood loss, ml (400 vs 100, ( = 0.0001)) requiring blood transfusion (14% vs 4.3%) ( = 0.03), higher intraoperative complication (21% vs 6%) ( = 0.0004), and post op complications (17% vs 5.3%) ( = 0.01). Amongst the MIS (RA vs LA), RA appeared be have better outcomes in terms of shorter operative time, less blood loss and less intra operative complications with a value <0.05. These results were consistent for the assessment of patients who had ⩾6 cm tumor size. The postoperative complication rates were lowest with RA (3.3%) compared to OA (17%) and LA (6.1%).
Contemporary practice of adrenalectomy shows that robotic adrenalectomy is safe and effective irrespective of the tumor size.
对于大型肾上腺肿瘤,微创外科手术(MIS)仍存在争议。本研究的目的是评估在三个机构中接受(开放手术=OA、腹腔镜手术=LA 和机器人手术=RA)肾上腺切除术的患者的当代围手术期结局。
回顾性收集了 2013 年至 2020 年期间在三个机构接受肾上腺切除术的 235 例患者的围手术期和术后数据。所有患者均进行了彻底的影像学和内分泌检查。
评估了 235 例接受肾上腺切除术的患者(OA(=29)、LA(=146)和 RA(=60))。OA(=29)与微创手术(=206)相比,肿瘤大小(cm)(中位数, 值)显著更大(9.4 与 5,(=0.0001)),手术时间更长(min)(240 与 100,(=0.0001)),住院时间更长(天)(8 与 3,(=0.0001)),再入院率更高(14%与 1.9%),出血量更多(ml)(400 与 100,(=0.0001))需要输血(14%与 4.3%)(=0.03),术中并发症更高(21%与 6%)(=0.0004),术后并发症更高(17%与 5.3%)(=0.01)。在微创手术(RA 与 LA)中,RA 在手术时间更短、出血量更少、术中并发症更少方面表现出更好的结果, 值<0.05。这些结果对于评估肿瘤大小 ⩾6cm 的患者是一致的。RA 的术后并发症发生率最低(3.3%),低于 OA(17%)和 LA(6.1%)。
当代肾上腺切除术的实践表明,机器人肾上腺切除术是安全有效的,与肿瘤大小无关。